Medisca Launches Global Peptide Division
Medisca has launched a new global division focused on expanding access to API-grade peptides, enhancing the pharmaceutical and personalized medicine landscape. This initiative reflects a strong commitment to building the necessary capabilities and infrastructure to support high-quality peptide production within regulatory frameworks. The development is a positive step towards improving the availability of personalized treatments.
MONTREAL — Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and personalized medicine markets worldwide. As the peptide landscape evolves, Medisca is pr…
Financial Post
